Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Pancreatitis risk associated with GLP-1 receptor agonists, considered as a single class, in a comorbidity-free subgroup of type 2 diabetes patients in the United States: a propensity score-matched analysis
Post-matching survival analysis utilized Kaplan-Meier estimation, while treatment effects were quantified through Cox proportional hazards models, yielding hazard ratios (HRs) with 95% confidence intervals (CIs) and P values
It slows more than expected
Presented for research literature review only Hayman S et al
29, 124140.e110
"Update on FDA's ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity"
US$ 26.84
US$ 23.73
US$ 20.38
US$ 28.67
US$ 29.48
US$ 28.59
